Neumann U, Schechter N M, Gütschow M
Novartis Pharma AG, Basel, Switzerland.
Bioorg Med Chem. 2001 Apr;9(4):947-54. doi: 10.1016/s0968-0896(00)00310-2.
A series of 2-sec.amino-4H-3,1-benzoxazin-4-ones was evaluated as acyl-enzyme inhibitors of human recombinant chymase. The compounds were also assayed for inhibition of human cathepsin G, bovine chymotrypsin, and human leukocyte elastase. Introduction of an aromatic moiety into the 2-substituent resulted in strong inhibition of chymase, cathepsin G, and chymotrypsin. Extension of the N(Me)CH2Ph substituent by one methylene unit was unfavourable to inhibit these proteases. Towards chymase, 2-(N-benzyl-N-methylamino)-4H-3,1-benzoxazin-4-one (32) and 2-(N-benzyl-N-methylamino)-6-methyl-4H-3,1-benzoxazin-4-one (33) were found to exhibit Ki values of 11 and 17 nM, respectively, and form stable acyl-enzymes with half-lives of 53 and 25 min, respectively. Benzoxazinone 33 also inhibited the human chymase-catalyzed formation of angiotensin 11 from angiotensin I.
评估了一系列2-氨基-4H-3,1-苯并恶嗪-4-酮作为人重组糜酶的酰基酶抑制剂。还测定了这些化合物对人组织蛋白酶G、牛胰凝乳蛋白酶和人白细胞弹性蛋白酶的抑制作用。在2-取代基中引入芳基部分会导致对糜酶、组织蛋白酶G和胰凝乳蛋白酶的强烈抑制。将N(Me)CH2Ph取代基延长一个亚甲基单元不利于抑制这些蛋白酶。对于糜酶,发现2-(N-苄基-N-甲基氨基)-4H-3,1-苯并恶嗪-4-酮(32)和2-(N-苄基-N-甲基氨基)-6-甲基-4H-3,1-苯并恶嗪-4-酮(33)的Ki值分别为11和17 nM,并且分别形成半衰期为53和25分钟的稳定酰基酶。苯并恶嗪酮33还抑制人糜酶催化的血管紧张素I形成血管紧张素II。